IgA ANTI-GLIADIN ANTIBODIES AND JEJUNAL MUCOSAL LESIONS IN HEALTHY BLOOD DONORS

J. Hed, Lennart Franzén, Gudrun Liedén, Ewa Ottosson, A. Walan(Linköping University), Magnus Ström(Linköping University), Florence Sjögren, O Groth

The Lancet

July 1, 1986

10.1016/s0140-6736(86)92508-0

Cited by 68

Related Papers

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa

|Gastroenterology|2000|544

Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer

|New England Journal of Medicine|1989|382

Cure of <i>Helicobacter pylori</i> infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

|Gut|2003|220

Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis

|British journal of surgery|2007|171

MAINTENANCE TREATMENT OF RECURRENT PEPTIC ULCER BY CIMETIDINE

|The Lancet|1978|170